Logo image of CON

CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

USA - NYSE:CON - US20603L1026 - Common Stock

20.66 USD
-0.36 (-1.71%)
Last: 9/19/2025, 8:04:00 PM
20.66 USD
0 (0%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

4

Overall CON gets a fundamental rating of 4 out of 10. We evaluated CON against 101 industry peers in the Health Care Providers & Services industry. CON has a medium profitability rating, but doesn't score so well on its financial health evaluation. CON is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CON had positive earnings in the past year.
In the past year CON had a positive cash flow from operations.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

With an excellent Return On Assets value of 5.24%, CON belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
The Return On Equity of CON (43.45%) is better than 98.02% of its industry peers.
CON's Return On Invested Capital of 10.98% is amongst the best of the industry. CON outperforms 83.17% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CON is significantly above the industry average of 9.19%.
The last Return On Invested Capital (10.98%) for CON is well below the 3 year average (23.70%), which needs to be investigated, but indicates that CON had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.24%
ROE 43.45%
ROIC 10.98%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

CON has a Profit Margin of 7.42%. This is amongst the best in the industry. CON outperforms 88.12% of its industry peers.
CON's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 15.66%, CON belongs to the best of the industry, outperforming 92.08% of the companies in the same industry.
In the last couple of years the Operating Margin of CON has declined.
CON has a Gross Margin of 28.10%. This is comparable to the rest of the industry: CON outperforms 55.45% of its industry peers.
In the last couple of years the Gross Margin of CON has declined.
Industry RankSector Rank
OM 15.66%
PM (TTM) 7.42%
GM 28.1%
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

2

2. Health

2.1 Basic Checks

CON has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CON has more shares outstanding
CON has a worse debt/assets ratio than last year.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that CON is in the distress zone and has some risk of bankruptcy.
CON's Altman-Z score of 1.77 is in line compared to the rest of the industry. CON outperforms 41.58% of its industry peers.
The Debt to FCF ratio of CON is 8.91, which is on the high side as it means it would take CON, 8.91 years of fcf income to pay off all of its debts.
CON has a Debt to FCF ratio (8.91) which is in line with its industry peers.
CON has a Debt/Equity ratio of 4.82. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 4.82, CON is doing worse than 79.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF 8.91
Altman-Z 1.77
ROIC/WACC1.28
WACC8.6%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B

2.3 Liquidity

A Current Ratio of 1.18 indicates that CON should not have too much problems paying its short term obligations.
CON's Current ratio of 1.18 is on the low side compared to the rest of the industry. CON is outperformed by 62.38% of its industry peers.
CON has a Quick Ratio of 1.18. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
CON has a Quick ratio (1.18) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

CON shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.72%.
The Earnings Per Share has been decreasing by -3.99% on average over the past years.
Looking at the last year, CON shows a small growth in Revenue. The Revenue has grown by 3.38% in the last year.
Measured over the past years, CON shows a small growth in Revenue. The Revenue has been growing by 3.14% on average per year.
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-26%
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%15.25%

3.2 Future

CON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.09% yearly.
The Revenue is expected to grow by 8.92% on average over the next years. This is quite good.
EPS Next Y-6.62%
EPS Next 2Y5.41%
EPS Next 3Y8.09%
EPS Next 5YN/A
Revenue Next Year13.08%
Revenue Next 2Y10.45%
Revenue Next 3Y8.92%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.80, CON is valued correctly.
Based on the Price/Earnings ratio, CON is valued a bit cheaper than 79.21% of the companies in the same industry.
CON's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.38.
Based on the Price/Forward Earnings ratio of 13.21, the valuation of CON can be described as correct.
CON's Price/Forward Earnings ratio is rather cheap when compared to the industry. CON is cheaper than 80.20% of the companies in the same industry.
CON's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.86.
Industry RankSector Rank
PE 16.8
Fwd PE 13.21
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CON is valued a bit cheaper than 68.32% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CON is valued a bit cheaper than the industry average as 78.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.17
EV/EBITDA 11.14
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

The decent profitability rating of CON may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.41%
EPS Next 3Y8.09%

3

5. Dividend

5.1 Amount

CON has a Yearly Dividend Yield of 1.19%. Purely for dividend investing, there may be better candidates out there.
CON's Dividend Yield is rather good when compared to the industry average which is at 2.48. CON pays more dividend than 85.15% of the companies in the same industry.
With a Dividend Yield of 1.19, CON pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.19%

5.2 History

CON is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15

5.3 Sustainability

16.11% of the earnings are spent on dividend by CON. This is a low number and sustainable payout ratio.
DP16.11%
EPS Next 2Y5.41%
EPS Next 3Y8.09%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 100M 200M 300M 400M 500M
CON Dividend Payout.CON Dividend Payout, showing the Payout Ratio.CON Dividend Payout.PayoutRetained Earnings

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (9/19/2025, 8:04:00 PM)

After market: 20.66 0 (0%)

20.66

-0.36 (-1.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-27 2025-10-27
Inst Owners84.54%
Inst Owner Change-13.05%
Ins Owners7.38%
Ins Owner Change0%
Market Cap2.65B
Analysts81.67
Price Target28.05 (35.77%)
Short Float %2.12%
Short Ratio2.71
Dividend
Industry RankSector Rank
Dividend Yield 1.19%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP16.11%
Div Incr Years0
Div Non Decr Years1
Ex-Date08-21 2025-08-21 (0.0625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.03%
Min EPS beat(2)-2.63%
Max EPS beat(2)0.58%
EPS beat(4)3
Avg EPS beat(4)0.6%
Min EPS beat(4)-2.63%
Max EPS beat(4)3.19%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.68%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)1.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.77%
PT rev (3m)-0.77%
EPS NQ rev (1m)1.24%
EPS NQ rev (3m)-4.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.15%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 16.8
Fwd PE 13.21
P/S 1.32
P/FCF 14.17
P/OCF 10.2
P/B 7.73
P/tB N/A
EV/EBITDA 11.14
EPS(TTM)1.23
EY5.95%
EPS(NY)1.56
Fwd EY7.57%
FCF(TTM)1.46
FCFY7.06%
OCF(TTM)2.03
OCFY9.81%
SpS15.65
BVpS2.67
TBVpS-10.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.24%
ROE 43.45%
ROCE 12.54%
ROIC 10.98%
ROICexc 11.32%
ROICexgc 39.62%
OM 15.66%
PM (TTM) 7.42%
GM 28.1%
FCFM 9.32%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
ROICexc(3y)24.7%
ROICexc(5y)N/A
ROICexgc(3y)89.31%
ROICexgc(5y)N/A
ROCE(3y)27.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF 8.91
Debt/EBITDA 4.34
Cap/Depr 109.56%
Cap/Sales 3.63%
Interest Coverage 3.72
Cash Conversion 68.22%
Profit Quality 125.56%
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.77
F-Score4
WACC8.6%
ROIC/WACC1.28
Cap/Depr(3y)84.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)N/A
Profit Quality(3y)135.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-26%
EPS Next Y-6.62%
EPS Next 2Y5.41%
EPS Next 3Y8.09%
EPS Next 5YN/A
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%15.25%
Revenue Next Year13.08%
Revenue Next 2Y10.45%
Revenue Next 3Y8.92%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3Y-0.08%
EBIT growth 5YN/A
EBIT Next Year37.66%
EBIT Next 3Y18.3%
EBIT Next 5YN/A
FCF growth 1Y21.47%
FCF growth 3Y-3.19%
FCF growth 5YN/A
OCF growth 1Y17.23%
OCF growth 3Y-1.87%
OCF growth 5YN/A